Abstract
AbstractThe 2016 IUPAC-Richter Prize in Medicinal Chemistry has been awarded to Dr. Michael J. Sofia. Dr. Sofia received this award in recognition of his outstanding creative contributions to the invention, discovery, and development of the novel antiviral drug sofosbuvir (Sovaldi™) as a treatment for the cure of hepatitis C virus infection. It was approved in 2013. This new drug and its combinations provide high cure rates in infected people.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
